Malissa Wood
Cardiovascular Disease · Fort Myers, FLNPI 1154312056
Payments from drug & device makers
Across 245 payments — averaging $1019.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Heartflow, Inc.$111K
- AbbVie$77K
- Pfizer$27K
- Abiomed$24K
- Madrigal Pharmaceuticals$5K
- Sanofi-aventis U.S. LLC$2K
- plus $4K from 7 others
Across 31 payments — averaging $1217.15 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Quidel Corporation$19K
- AbbVie$16K
- Ortho-clinical Diagnostics, Inc.$3K
What the payments were for
- Consulting fees$113,50845%
- Speaking & faculty fees$117,80047%
- Travel & lodging$14,9886%
- Food & beverage$3,3511%
- Education$190%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Heartflow, Inc. | 61 | $111,379 |
| AbbVie | 85 | $76,712 |
| Pfizer | 46 | $26,699 |
| Abiomed | 14 | $23,522 |
| Madrigal Pharmaceuticals | 20 | $4,867 |
| Sanofi-aventis U.S. LLC | 1 | $2,366 |
| E.r. Squibb & Sons, L.L.C. | 1 | $1,920 |
| Edwards Lifesciences | 9 | $1,477 |
| Medtronic | 3 | $215 |
| Boehringer Ingelheim | 2 | $202 |
| Kestra Medical Technology Services, Inc. | 1 | $114 |
| Abbott | 1 | $100 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $96 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FFRct$111,326
- Skyrizi$27,225
- Impella$23,363
- Rinvoq$19,396
- REZDIFFRA$4,867
- MULTAQ$2,366
- Edwards SAPIEN 3 Transcatheter Heart Valve$1,227
- COREVALVE EVOLUT R$175
- SAPIEN 3 Ultra RESILIA$175
- Assure WCD$114
- VYNDAQEL$105
How this compares
$249,666 in reported general payments places this provider in the 90th percentile of 1,740 cardiovascular disease providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Metoprolol Succinate | 13 | $314 |
| Atorvastatin Calcium | 16 | $198 |
| Simvastatin | 11 | $113 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Fort Myers
- Michael KorenGainesville$31M
- Seth BaumBoca Raton$11.1M
- Alexis GutierrezHialeah$8M
- Eric SpivackAventura$7.1M
- William OneillNaples$4.6M
- Rafik AbadierInverness$4.4M
- Alvaro MurciaPembroke Pines$4M
- David HotchkissPort Charlotte$4M
- Ferris GeorgeSt Augustine$3.8M
- Duccio BaldariWellington$3.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.